SCHEMBL5813440

SCHEMBL5813440

COc1ccc(-c2nc(N3CCN(C)CC3)sc2-c2ccnc(NC3CC3)n2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.64
IKBKB O14920 3/20 0.48
HTR6 P50406 1/20 0.46
HRH4 Q9H3N8 1/20 0.45
KCNH2 Q12809 2/20 0.44
PTGS2 P35354 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
GLA P06280 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
PTGS1 P23219 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
EGFR P00533 3/20 0.44
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5812763 0.96 KMT2A (0.61) KMT2AIKBKBHTR6HRH4KCNH2
SCHEMBL5818777 0.95 KMT2A (0.60) KMT2AIKBKBHTR6HRH4KCNH2
SCHEMBL5818512 0.91 KMT2A (0.50) KMT2AIKBKBKCNH2ALDH1A1EGFR
SCHEMBL5816363 0.90 KCNH2 (0.53) KMT2AIKBKBKCNH2EGFRACHE
SCHEMBL5815226 0.89 KMT2A (0.50) KMT2AIKBKBHTR6HRH4KCNH2
SCHEMBL5814477 0.89 KCNH2 (0.55) IKBKBKCNH2EGFR
SCHEMBL5813351 0.87 KMT2A (0.48) KMT2AIKBKBHTR6HRH4KCNH2
SCHEMBL5819339 0.86 KMT2A (0.48) KMT2AIKBKBHTR6HRH4KCNH2
SCHEMBL5817757 0.86 KCNH2 (0.53) KMT2AIKBKBKCNH2
SCHEMBL5813636 0.86 ALDH1A1 (0.48) KMT2AKDM4EMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed